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Summary: A new method for phenotyping human serum arylesterase (EC 3.1.1.2) is described and evaluated.
The aromatic esters, phenyl acetate and 4-nitrophenyl acetate, were compared as substrates for spectropho-
tometric measurement of arylesterase activity. A method for arylesterase phenotyping, based upon inhibition
of the enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetete, was developed. The method was
applied to serum samples from 158 blood donors and showed a distinct separation of the three phenotypes
defined by a reference method based on the ratio of paraoxonase activity to arylesterase activity using
paraoxon and phenyl acetate as substrates. The method was adapted to a Cobas-Fara centrifugal analyser.
Introduction
Human serum possesses enzymatic activity capable of
hydrolysing several aromatic carboxylic acid esters
(e. g. phenyl acetate (1), ^ -nitrophenyl acetate (2), and
2-naphthyl acetate (1)) and organophosphate com-
pounds (e. g. diethyl /?-nitrophenyl phosphate (para-
oxon) (3), chlorpyrifos oxon (4), and diisopropyl fluo-
rophosphate (5)). A single enzyme species classified
as arylesterase (A-esterase, paraoxonase, arylester hy-
drolase, EC 3.1.1.2)1) accounts for nearly all of these
activities (5).
Arylesterase is a glycoprotein closely associated with
the high density lipoprotein complex; MT: 43 000; con-
centration: approximately 50 mg/1 serum (5). Accord-
ing to a hypothesis of Eckerson et al. (3), the enzyme
exists in two allozymic forms (isozyme A and isozyme
B) which are controlled by two allels, ESA*A and
ESA*B, at a single autosomal gene locus.
A number of chemical methods, based on quantita-
tively different kinetic properties of the two isozymes,
have been developed to separate the two homozygous
Enzyme: Arylesterase, A-esterase, paraoxonase, arylester hy-
drolase (EC 3.1.1.2).
phenotypes A and B, and the heterozygous phenotype
AB (3, 4, 6, 7). Using paraoxon as substrate, the two
isozymes differ with respect to NaCl-stimulation (6),
CaCl2-stimulation (6, 7), pH optimum (8), Km value
(9), and mean-activity level (8), and they differ in the
ratio of paraoxonase activity to arylesterase activity
(substrate: phenyl acetate) (3). The method described
by Eckerson et al. (3), which we used as the reference
method, is based on this ratio.
The present paper describes and evaluates a new
method for phenotyping arylesterase in crude serum.
The two substrates used are phenyl acetate and p-
nitrophenyl acetate; these esters have been used as
substrates in several studies for measuring arylesterase
activity and are rather specific for this enzyme (2, 10,
11, 12). As shown in this study, there seems to be a
trimodal relation between the enzymatic hydrolysis of
the two substrates in a larger number of samples. This
suggests that /?-nitrophenyl acetate, like paraoxon,
could be a "discriminating" substrate applicable for
phenotyping arylesterase. In order to design a method
without UV-photometry and adaptable for a Cobas-
Fara centrifugal analyser, we studied the inhibition
of the enzymatic hydrolysis of /?-nitrophenyl acetate
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by phenyl acetate and developed a method based on
the inhibition characteristics. The phenotyping de-
fined by the new method was compared with the
phenotyping defined by the reference method.
Materials and Methods
Samples
Serum samples were obtained from blood donors in a Danish
population. The samples were stored frozen at —20 °C.
Arylesterase activity with phenyl acetate as sub
strate
In this assay the arylesterase activity was measured as described
by Eckerson et al. (3). The reaction mixture contained 1.0
mmol/1 phenyl acetate (Sigma P-2396) and 0.9 mmol/1 CaCl2
in 9.0 mmol/1 tris(hydroxymethyl)aminomethane/HCl buffer
pH 8.0. The reaction was initiated by adding a 20 μΐ sample,
prediluted with buffer 1 + 3, to 3.0 ml buffer/substrate reagent.
The initial velocity of phenol formation during the hydrolysis
of phenyl acetate was calculated from the increase of A270nm
recorded on a PM4 QII spectrophotometer (Zeiss, Germany);
ε27θηιη: 157 m2/mol; reaction temperature: 25 °C. The progress
curves were linear for at least 60 s. Blanks were used to correct
for non-enzymatic hydrolysis. All samples were run in duplicate.
Arylesterase activity with 4-nitrophenyl acetate as
substrate
The reaction mixture contained 0.5 mmol/1 /?-nitrophenyl ace-
tate (Sigma Ν 8130) and 1.0 mmol/1 CaQ2 in 50 mmol/1
Tris(hydroxymethyl)aminomethane/HCl buffer pH 8.O. The re-
action was initiated by adding 5 μΐ sample, prediluted with
buffer 1 + 6, to the buffer/substrate reagent; final volume: 360
μΐ. The velocity of /?-nitrophenol formation during the hydrol-
ysis of /?-nitrophenyl acetate was recorded at 400 nm on a
Cobas-Fara centrifugal analyser (Roche Ltd., Basel Switzer-
land) as a kinetic assay (20 to 50 s); 8400 nm' 1640 m2/mol; reaction
temperature: 25 °C. Blanks were used to correct for non-enzy-
matic hydrolysis. All samples were run in duplicate.
Paraoxonase activity
Paraoxonase activity was measured by adapting the procedure
described by Eckerson et al. (3) to a Cobas-Fara centrifugal
analyser. The reaction mixture contained 1.0 mmol/1 diethyl p-
nitrophenyl phosphate (Sigma D 9286), 1.0 mmol/1 CaCl2 and
1.0 mol/1 NaCl in 50 mmol/1 glycine buffer pH 10.5. The
reaction was initiated by adding 20 μΐ sample, prediluted with
buffer 1 + 20, to the buffer/substrate reagent; final volume:
380 μΐ. The initial velocity of /?-nitrophenol formation was
recorded at 400 nm; 8400 nm' 1810 m2/mol; reaction temperature:
25 °C. The progress curves were linear for at least 120 s. Blanks
were used to correct for non-enzymatic hydrolysis. All samples
were run in duplicate.
Inhibition of enzymatic hydrolysis of 4-nitrophenyl
acetate by phenyl acetate
For determination of the non-inhibited arylesterase activity, the
substrate concentration was 0.5 mmol/1 /?-nitrophenyl acetate
(Sigma N 8130); for determination fo the inhibited arylesterase
activity, the substrate concentrations were 0.5 mmol/1 /7-nitro-
phenyl acetate and 1.0 mmol/1 phenyl acetate (Sigma P-2396).
In both cases the reaction mixture contained 1.0 mmol/1 CaCl2
and 1.0 mol/1 NaCl in 25 mmol/1 triethanolamine hydrochloride
buffer pH 7.4. A stock solution of/7-nitrophenyl acetate (1.27
mmol/1) was prepared in distilled water; the buffer including
the salts, with or without phenyl acetate, was added just before
use to minimize non-enzymatic hydrolysis. The reaction was
initiated by adding 20 μΐ sample, prediluted with buffer 1 + 20,
to the buffer/substrate reagent; final volume: 380 μΐ. The ve-
locity of /?-nitrophenol formation was recorded at 400 nm on
a Cobas-Fara centrifugal analyser as a kinetic assay (40 to 95 s);
B4oonm: 1400 m2/mol; reaction temperature: 25 °C. Blanks were
used to correct for non-enzymatic hydrolysis.
Molar absorbances and statistics
The molar absorbances of phenol and p-nitrophenol used in
the calculations were determined on a PM4 QII spectropho-
tometer (Zeiss, Germany) at the specified pH values and wave-
lengths. Phenol stock standard (Sigma 960-25) and p-nitro-
phenol standard solution (Sigma 104-1) were used as standards.
All statistics were performed on an IBM PC/AT using the SPSS/
PC+ software package (SPSS Inc., Chicago, IL).
Results
Enzymatic hydrolysis of 4-nitrophenyl ace-
tate versus enzymatic hydrolysis of phenyl
acetate
Figure 1 shows the arylesterase activities in 50 ran-
domly selected sera using phenyl acetate and /7-nitro-
phenyl acetate as substrates. No simple linear relation
was observed. As indicated by the three lines in the
figure, data are more probably described by three
different linear relations.
Inhibition of enzymatic hydrolysis of 4-ni-
trophenyl acetate by phenyl acetate
Figure 2 shows the inhibited and non-inhibited aryl-
esterase activities in 158 randomly selected sera, using
/7-nitrophenyl acetate as substrate and phenyl acetate
as inhibitor. As indicated by the line in the figure, a
cluster of points with a very high, linear correlation
between inhibited (IA) and non-inhibited arylesterase
(ΝΙΑ) activity is clearly identified (IA = 0.428
χ ΝΙΑ + 0.15 kU/1; r = 9.996). Figure 3 shows the
distribution of the figure X = (IA — IA0)/NIA using
IA0 =0.15 kU/1 (ordinate intercept). The samples
were segregated into three distinct groups with no
overlap (Gl: X < 0.24, N = 15; G2: 0.24 < X
< 0.37, N = 72; G3: Χ > 0.37, Ν = 71).
Analytic inaccuracy of (IA — IA0)/NIA was estimated
from repeated analysis (N = 56) of one sample from
each of the three groups. To examine the influence of
non-specific arylesterase activity from other carbox-
ylic ester hydrolases (10 — 12), an additional assay
with preincubation of the samples in 1.0 μηιοΐ/ΐ para-
oxon for 60 min at 25 °C was performed. Table 1
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Fig. 1. Arylesterase catalytic activity concentrations in 50 ran-
domly selected sera using phenyl acetate and p-nitro-
phenyl acetate as substrates. The three lines indicate the
suggested trimodal pattern of distribution.
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Fig. 2. Inhibition of enzymatic hydrolysis of p-nitrophenyl ace-
tate by phenyl acetate in 158 randomly selected sera. A
cluster of points is clearly identified as indicated by the
line (IAo: ordinate intercept).
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Fig. 3. Distribution of the quotient (inhibited arylesterase mi-
nus IAo)/non-inhibited arylesterase within 158 randomly
selected sera. IA0: ordinate intercept of the line in figure
2. Three groups Gl, G2, and G3 are clearly separated.
shows means and standard deviations (total, analyt-
ical and biological) of (IA—IA0)/NIA within the
groups Gl, G2, and G3.
Ten samples from each group were phenotyped ac-
cording to the method of Eckerson et al. (3). The
phenotypes (A, AB, and B) were determined by cal-
culating the ratio (p/a) of paraoxonase activity (p) to
arylesterase activity (a) using paraoxon and phenyl
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Fig. 4. Reaction kinetics of the arylesterase isozyme (G3). The
catalytic activity concentrations (b) of /?-nitrophenyl
acetate hydrolysis at the substrate concentrations ([S])
1.00 mmol/l, 0.33 mmol/l, 0.20 mmol/l, and 0.14 mmol/l
were measured at various concentrations of phenyl ace-
tate (inhibitor): 0.0 mmol/l (A), 0.5 mmol/l (+), 1.0
mmol/l (·), and 2.0 mmol/l (·). Insert: slopes of the
lines in the main figure as a function of inhibitor con-
centration.
acetate as substrates (A: p/a < 5.5 χ 10~3, AB: 5.5
x ΙΟ'3 < p/a < 13.5 χ KT3 and B: p/a > 13.5
χ 10~3). All samples from G3 were of the phenotype
A, and all samples from G2 were of the phenotype
Tab. 1. Means and standard deviations of (IA —IA0)/NIA within the groups Gl, G2, and G3.
*: SDL,. =
Without preincubation
(paraoxon 1 μιηοΐ/ΐ)
After preincubation
(paraoxon 1 μηιοΐ/ΐ)
Repeated measurements
(one sample from each group)
Gl G2 G3 Gl G2 G3 Gl G2
- SDL
G3
Ν
Mean
SDtotai
SDerror
SDbiol*
15
0.2206
0.0080
—
0.0070
72
0.2884
0.0163
—
0.0158
71
0.4269
0.0084
—
0.0062
14
0.2154
0.0078
—
—
72
0.2841
0.0159
—
—
70
0.4277
0.0099
—
—
55
0.2213
—
0.0038
—
56
0.3020
—
0.0039
—
55
0.4392
—0.0057
.—
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AB; from Gl, nine samples were of phenotype B and
one sample was of phenotype AB (p/a = 12.0 χ 10~3;
Χ = 0.225).
Reaction kinetics of the arylesterase iso-
zymes
The catalytic hydrolysis of /7-nitrophenyl acetate at
various concentrations of /?-nitrophenyl acetate and
phenyl acetate was measured using samples from Gl
and G3 (two samples from each group were run in
duplicate).
Figure 4 shows a double-reciprocal plot using a sam-
ple from G3. A similar plot was obtained using a
sample from Gl (not shown). The reaction kinetics
exclude simple competitive and uncompetitive inhi-
bition, but is consistent with the model of non-com-
petitive inhibition (1/v = (Km/Vm&x) (1 + i/ΐζ) (1/s)
+ (l/Vmax) (1 + Ί/KiJ). Km was estimated to be 0.31
mmol/1 (Gl) and 0.40 mmol/1 (G3). K{ was estimated
to be 0.21 mmol/1 (Gl) and 0.60 mmol/1 (G3) from
inhibitor concentrations and slopes of the lines in the
double-reciprocal plot (slope = (A:m/Vmax) (1 + i/
Discussion
The method described clearly divides the samples into
three distinct groups, Gl, G2, and G3. The segrega-
tion pattern observed is consistent with a two-allele
model with co-dominant expression. According to this
model the frequencies of the alleles in the sample
population were estimated to be 0.323 and 0.677. The
observed distribution of the samples (Gl: 15, G2: 72,
and G3: 71) accords with the expected distribution
(Gl: 16.5, G2: 69.1, and G3: 72.4), assuming the
population to be in Hardy-Weinberg equilibrium with
respect to the two alleles (χ2 = 0.284; 0.80 < ρ
< 0.90). Comparing the new method of arylesterase
phenotyping with the reference method, 29 of 30
samples were identically segregated into three subsets,
and only 1 sample was assigned differently. It seems
justified to consider that the phenotyping of the two
methods is essentially the same, with the groups Gl,
G2, and G3 corresponding to the phenotypes B, AB,
and A. According to Eckerson et al. (3) the frequency
of the ESA*A allele is 0.685 and that of the ESA*B
allele is 0.315 in a population of Caucasians. The
allele frequencies found in the present study are quite
close to these figures.
Preincubation of the samples in paraoxon did not
change the grouping of any sample and, as shown in
table 1, the total standard deviation of the figure
(IA — IAo)/NIA was not reduced. It is concluded that
the results for non-specific arylesterase activity are
negligibly affected by the presence of other carboxylic
ester hydrolases, including cholinesterase, and that
such affects cannot contribute to the biological stand-
ard deviation of the groups. Ortigoza-Ferado et al.
(13) found that albumin has a paraoxonase activity
which is not negligible at high pH values. This non-
specific activity presumably interferes with the para-
oxonase activity measurements used in the reference
method for phenotyping. Whether similar interference
accounts for some of the biological standard deviation
in the new method has not been examined.
The biological standard deviation of the intermediate
group, G2, is more than twice the biological standard
deviation of Gl and G3. This observation could pos-
sibly be explained by an inter-individual variation in
the proportion of the activities of the two isozymes
in heterozygous individuals.
Phenyl acetate and paraoxon are the two substrates
used for arylesterase phenotyping in most methods
published. Apparently the turnover number of the
two isozymes differ with paraoxon, whereas they are
identical with phenyl acetate (3, 14). In this study it
is demonstrated that^-nitrophenyl acetate can be used
instead of paraoxon as a substrate for differentiating
the isozymes. The difference between the Kj values of
the isozymes (0.60 mmol/1 and 0.21 mmol/1) is re-
sponsible for the segregation.
The assay conditions used were selected to optimize
the separation of the three phenotype groups. The
main problem is the low solubility, 0.6 g/1 water, and
the relatively high spontaneous hydrolysis (11) of p-
nitrophenyl acetate. The pH value 7.4 and the reaction
temperature 25 °C were selected to suppress the spon-
taneous hydrolysis. It was found that 1.0 mol/1 NaCl
signficantly enhanced the separation of the groups;
CaCl2 was added to secure adequate expression of
enzyme activity (15 — 17).
The method described is an easy and non-toxic
method for large scale phenotyping and activity quan-
titation of arylesterase. The method is suitable for
studies on the physiological functions of the enzyme
and its relationship to pathological conditions (e. g.
liver cirrhosis (18), familial hypercholesterolaemia,
and insulin-dependent diabetes mellitus (19)).
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